THE PATHOBIOLOGY OF MACAQUE RETROVIRUSES CLOSELY RELATED TO HUMAN T CELL LYMPHOTROPIC VIRUSES NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


THE PATHOBIOLOGY OF MACAQUE RETROVIRUSES CLOSELY RELATED TO HUMAN T CELL LYMPHOTROPIC VIRUSES

Animal Models of Retrovirus Infection and Their Relationship to AIDS. Salzman LA, ed. Orlando, Florida, Academic Press, p. 223-32, 1986.. Unique Identifier : AIDSLINE ICDB/87629278
Kanki PJ; Hunt RD; Essex ME; Dept. of Cancer Biology, Harvard Sch. of Public Health, Boston,; MA


Abstract: The macaque monkey is naturally infected with two T lymphotropic retroviruses, one closely related to HTLV-I (human T cell lymphotropic virus type I) and the second more closely related to HTLV-III (human T lymphotropic virus type III); these have been designated STLV-I and STLV-III, respectively. Studies of these primate viruses indicate numerous parallels to the human systems and could provide a relevant model system for the understanding of HTLV viruses and the pathogenesis of their associated diseases. Phytohemagglutinin-stimulated lymphocytes from seropositive macaques showed type C virus particles identical to HTLV-I after 6 days in short-term culture. In cocultivation procedures, the macaque virus was capable of transforming seronegative macaque and human lymphocytes. The HTLV-I-transformed cells exhibited the adult T cell leukemia antigen when tested with the appropriate antisera in a fixed immunofluorescence assay. It appears that the STLV-I virus is very closely related to HTLV-I by major antigen cross-reactivity. It also appears that STLV-I, like its human counterpart, may be associated with a spontaneous lymphoid abnormality. The macaque retrovirus STLV-III has been serologically identified and characterized by radioimmunoprecipitation techniques. Virus-specific proteins of 160 kilodaltons (kD), 120 kD, 55 kD, and 24 kD were identified; all similar in size to the major gag- and env-encoded proteins of HTLV-III. These protein species were similarly recognized by macaque serum samples and human reference serum samples from acquired immune deficiency syndrome (AIDS)-related complex (ARC) and AIDS patients, positive for HTLV-III antibodies. Most of the macaques are apparently free of type D retrovirus, based on repeated unsuccessful isolation attempts and negative serology. The authors hypothesize that the macaque T lymphotropic retroviruses may be etiologically linked to an immunodeficiency syndrome, thus providing an animal model for the study of HTLV-III and the pathogenesis of AIDS. The close relationship of STLV-III to HTLV-III at an antigenic level may provide valuable insight into the development of an AIDS vaccine. (47 Refs)
Keywords: Acquired Immunodeficiency Syndrome/MICROBIOLOGY/*VETERINARY Animal Genes, Viral HIV/ISOLATION & PURIF HTLV-BLV Infections/MICROBIOLOGY/*VETERINARY HTLV-BLV Viruses/ISOLATION & PURIF Immunologic Techniques Macaca Monkey Diseases/*MICROBIOLOGY Retroviridae/*ISOLATION & PURIF/ULTRASTRUCTURE Retroviridae Proteins/ANALYSIS MONOGRAPH

KWDacquiredimmunodeficiencysyndrome/microbiology/KWDveterinaryanimalgenes,viralhiv/isolation&purifhtlv-blvinfections/microbiology/KWDveterinaryhtlv-blvviruses/isolation&purifimmunologictechniquesmacacamonkeydiseases/KWDmicrobiologyretroviridae/KWDisolation&purif/ultrastructureretroviridaeproteins/analysismonograph
870430
M8740278


Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .